Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2026-05-01 @ 12:23 PM
Study NCT ID:
NCT04606303
Status:
UNKNOWN
Last Update Posted:
2023-04-05
First Post:
2020-10-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.
Sponsor:
Peking University Cancer Hospital & Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Locally Advanced NSCLC | View |
Keywords: